Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China
· Delayed Price · Currency is CNY 24.43
+0.53 (2.22%)
Apr 22, 2025, 2:45 PM CST
SHA:600196 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 2,770 | 2,386 | 3,731 | 4,729 | 3,663 | Upgrade
|
| Depreciation & Amortization | 2,960 | 2,965 | 2,336 | 1,804 | 1,633 | Upgrade
|
| Other Amortization | 211.18 | 153.49 | 111.69 | 144.79 | 95.37 | Upgrade
|
| Loss (Gain) From Sale of Assets | -371.01 | -5.56 | -125.6 | 15.42 | -5.71 | Upgrade
|
| Asset Writedown & Restructuring Costs | 63.64 | 64.34 | 200.48 | 321.01 | 10.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2,035 | -2,988 | -1,832 | -4,491 | -495.61 | Upgrade
|
| Stock-Based Compensation | 21.07 | 35.9 | 54.48 | 64.29 | 55.22 | Upgrade
|
| Provision & Write-off of Bad Debts | 107.68 | 110.36 | 62.18 | 72.85 | 79.68 | Upgrade
|
| Other Operating Activities | 2,100 | 1,774 | 1,067 | 1,021 | -1,053 | Upgrade
|
| Change in Accounts Receivable | -397.52 | 1,605 | -2,077 | -1,795 | -1,560 | Upgrade
|
| Change in Inventory | 238.19 | -333.91 | -1,430 | -464.75 | -1,253 | Upgrade
|
| Change in Accounts Payable | -830.71 | -2,208 | 2,307 | 2,467 | 1,529 | Upgrade
|
| Operating Cash Flow | 4,477 | 3,414 | 4,218 | 3,938 | 2,580 | Upgrade
|
| Operating Cash Flow Growth | 31.13% | -19.05% | 7.10% | 52.64% | -19.94% | Upgrade
|
| Capital Expenditures | -4,410 | -5,337 | -5,889 | -4,973 | -4,437 | Upgrade
|
| Sale of Property, Plant & Equipment | 457.81 | 9.01 | 107.13 | 97.1 | 8.88 | Upgrade
|
| Cash Acquisitions | -215.79 | -924 | -1,197 | -1,307 | -153.94 | Upgrade
|
| Divestitures | 131.42 | 0.3 | 709.21 | 1,688 | 13.6 | Upgrade
|
| Investment in Securities | -668.06 | 1,568 | 1,225 | 214.13 | -706.25 | Upgrade
|
| Other Investing Activities | 1,091 | 863.84 | 980.64 | 422.65 | 568.6 | Upgrade
|
| Investing Cash Flow | -3,613 | -3,819 | -4,064 | -3,857 | -4,706 | Upgrade
|
| Long-Term Debt Issued | 31,773 | 23,514 | 30,649 | 29,529 | 17,973 | Upgrade
|
| Long-Term Debt Repaid | -31,396 | -22,041 | -26,280 | -27,392 | -15,708 | Upgrade
|
| Net Debt Issued (Repaid) | 377.42 | 1,472 | 4,369 | 2,137 | 2,265 | Upgrade
|
| Issuance of Common Stock | - | - | 4,509 | - | - | Upgrade
|
| Repurchase of Common Stock | -238.11 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -2,059 | -2,455 | -2,374 | -1,914 | -1,835 | Upgrade
|
| Other Financing Activities | 917.52 | -353.55 | -2,076 | -1,043 | 1,037 | Upgrade
|
| Financing Cash Flow | -1,003 | -1,336 | 4,428 | -819.41 | 1,467 | Upgrade
|
| Foreign Exchange Rate Adjustments | 27.99 | 73.65 | 128.34 | -134.71 | -300.16 | Upgrade
|
| Net Cash Flow | -110.94 | -1,668 | 4,710 | -873.79 | -959.49 | Upgrade
|
| Free Cash Flow | 66.79 | -1,922 | -1,671 | -1,035 | -1,857 | Upgrade
|
| Free Cash Flow Margin | 0.16% | -4.64% | -3.80% | -2.65% | -6.13% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | -0.72 | -0.64 | -0.40 | -0.72 | Upgrade
|
| Cash Income Tax Paid | 2,124 | 2,378 | 1,609 | 1,837 | 2,196 | Upgrade
|
| Levered Free Cash Flow | -274.97 | -4,046 | -1,692 | -1,087 | -2,787 | Upgrade
|
| Unlevered Free Cash Flow | 619.98 | -3,218 | -1,089 | -572.47 | -2,236 | Upgrade
|
| Change in Net Working Capital | 20.47 | 1,776 | -159.78 | -802.09 | 1,219 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.